LH - Laboratory Corporation of America Holdings
After hours:
| Previous Close | 212.44 |
| Open | 214.28 |
| Bid | 217.34 x 800 |
| Ask | 224.27 x 800 |
| Day's Range | 213.77 - 218.43 |
| 52 Week Range | 200.32 - 263.13 |
| Volume | |
| Avg. Volume | 589,119 |
| Market Cap | 19.224B |
| Beta (5Y Monthly) | 1.04 |
| PE Ratio (TTM) | 19.50 |
| EPS (TTM) | 11.13 |
| Earnings Date | Jul 26, 2023 - Jul 31, 2023 |
| Forward Dividend & Yield | 2.88 (1.36%) |
| Ex-Dividend Date | May 17, 2023 |
| 1y Target Est | 273.08 |
ZacksLabCorp (LH) Expands Precision Oncology With Biopsy Test
The addition of Labcorp Plasma Focus marks a pivotal step in the expansion of LabCorp's (LH) suite of precision oncology tests.
Simply Wall St.Is Laboratory Corporation of America Holdings (NYSE:LH) Potentially Undervalued?
Let's talk about the popular Laboratory Corporation of America Holdings ( NYSE:LH ). The company's shares saw...
Motley Fool3 No-Brainer Stocks to Buy in a Correction
NextEra Energy (NYSE: NEE) is a company well worth knowing about and adding to your watch list. The company bills itself as the world's largest utility company, and it can claim that in large part due to its ownership of the Florida Power & Light Company, which is itself "America's largest electric utility that sells more power than any other utility ..." There's a lot to like, or love, about NextEra Energy.
ZacksWhy Is LabCorp (LH) Down 2.7% Since Last Earnings Report?
LabCorp (LH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksLabCorp (LH) Expands Laboratory Relationship With New Pact
LabCorp's (LH) recent partnership will expand healthcare access, offer advanced diagnostic tools and guarantee that both patients and doctors can afford the treatments they get.
ZacksHere's Why Investors Should Retain LabCorp (LH) Stock for Now
Investors are optimistic about LabCorp (LH) on strategic partnerships and upbeat guidance.
- Zacks
LabCorp (LH) Base Business Growth Strong, Margin Pressure Stays
LabCorp (LH) is progressing well with its planned spin-off of the Clinical Development business, which is expected to be completed in mid-2023.
- Simply Wall St.
Just Four Days Till Laboratory Corporation of America Holdings (NYSE:LH) Will Be Trading Ex-Dividend
Laboratory Corporation of America Holdings ( NYSE:LH ) is about to trade ex-dividend in the next 4 days. The...
- Simply Wall St.
Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72
Laboratory Corporation of America Holdings ( NYSE:LH ) will pay a dividend of $0.72 on the 8th of June. This payment...
ZacksThe Zacks Analyst Blog Highlights BioRad Laboratories, Henry Schein, Insulet, Abbott and LabCorp
BioRad Laboratories, Henry Schein, Insulet, Abbott and LabCorp are included in this Analyst Blog.
Zacks3 MedTech Stocks Likely to Beat Estimates in Q1 Earnings
MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how BIO, HSIC and PODD are poised ahead of their earnings releases.
- Thomson Reuters StreetEvents
Q1 2023 Laboratory Corporation of America Holdings Earnings Call
Q1 2023 Laboratory Corporation of America Holdings Earnings Call
- Simply Wall St.
An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 40% Undervalued
Key Insights The projected fair value for Laboratory Corporation of America Holdings is US$387 based on 2 Stage Free...
- Zacks
LabCorp (LH) Q1 Earnings Miss Estimates, Margins Decline
The decline in COVID-19 PCR and antibody testing sales, the severe foreign exchange headwind and inflationary pressure hurt LabCorp's (LH) business performance in Q1.
ZacksCompared to Estimates, LabCorp (LH) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for LabCorp (LH) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- Reuters
Labcorp misses profit estimates as drug development unit struggles
Laboratory Corp of America Holdings missed estimates for quarterly profit on Tuesday, as its drug development unit struggled against curbs on animal imports, while a sharp fall in sales of COVID testing kits hurt its diagnostics business. Contract research firms, which conduct drug development-related work for third parties, have been hit by constraints over the supply of non-human primates (NHP) after a Cambodian supplier was charged in connection with illegal imports into the United States. The North Carolina-based life sciences company reported $1.4 billion in revenue from its drug development business for the quarter ended March 31, compared with analysts' estimate of $1.45 billion, according to Refinitiv IBES data.
ZacksLabCorp (LH) Misses Q1 Earnings Estimates
LabCorp (LH) delivered earnings and revenue surprises of -4.26% and 0.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
LabCorp (LH) to Report Q1 Earnings: What's in the Cards?
Ongoing sales rebound in the base business for both Diagnostics and Drug Development segments is likely to have benefited LabCorp (LH) in Q1.
- Simply Wall St.
Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72
The board of Laboratory Corporation of America Holdings ( NYSE:LH ) has announced that it will pay a dividend of $0.72...
ZacksLabCorp (LH) Expands Colon Cancer Test Access With New Pact
LabCorp's (LH) at-home collection kit will offer patients an additional and easier option to get screened for colon cancer.
- Simply Wall St.
Laboratory Corporation of America Holdings' (NYSE:LH) three-year earnings growth trails the stellar shareholder returns
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company...
- Zacks
LabCorp (LH) Focuses on High-Growth Areas Amid Currency Woe
In its efforts to expand further, LabCorp (LH) is focusing more on high-growth opportunity areas such as neurodegenerative, autoimmune and liver disease as well as cell and gene therapy.
ZacksTop Stock Reports for TotalEnergies, America Movil & Palo Alto Networks
Today's Research Daily features new research reports on 16 major stocks, including TotalEnergies SE (TTE), America Movil, S.A.B. de C.V. (AMX) and Palo Alto Networks, Inc. (PANW).
- Simply Wall St.
Returns Are Gaining Momentum At Laboratory Corporation of America Holdings (NYSE:LH)
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...
Business WireOvia HealthTM Expands Digital Platform Capabilities to Include Menopause Tracking
BOSTON, February 22, 2023--Ovia Health, a trusted digital health platform for women and families, today announced the expansion of its Ovia® app, which will now allow women to track menopause symptoms and access valuable resources and support to address the transition to menopause/perimenopause. The technology is available through Ovia’s consumer application and enterprise offerings for employers and health plans.
